Geron approved to test embryonic stem cells

Geron Corp. said it has been cleared by regulators to proceed with the first human test of an embryonic stem cell therapy, designed for patients with spinal-cord injuries. The shares rose as much as 16 percent …

[Read the full article here]

Comments are closed.